Cargando…
Metabolic associated fatty liver disease and COVID-19: a double whammy?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678140/ https://www.ncbi.nlm.nih.gov/pubmed/33047142 http://dx.doi.org/10.11622/smedj.2020141 |
| _version_ | 1784833930026811392 |
|---|---|
| author | Lin, Jaime Hui Xian Aravamudan, Veeraraghavan Meyyur |
| author_facet | Lin, Jaime Hui Xian Aravamudan, Veeraraghavan Meyyur |
| author_sort | Lin, Jaime Hui Xian |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9678140 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96781402022-11-22 Metabolic associated fatty liver disease and COVID-19: a double whammy? Lin, Jaime Hui Xian Aravamudan, Veeraraghavan Meyyur Singapore Med J Commentary Wolters Kluwer - Medknow 2020-09-21 /pmc/articles/PMC9678140/ /pubmed/33047142 http://dx.doi.org/10.11622/smedj.2020141 Text en Copyright: © 2022 Singapore Medical Journal https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Commentary Lin, Jaime Hui Xian Aravamudan, Veeraraghavan Meyyur Metabolic associated fatty liver disease and COVID-19: a double whammy? |
| title | Metabolic associated fatty liver disease and COVID-19: a double whammy? |
| title_full | Metabolic associated fatty liver disease and COVID-19: a double whammy? |
| title_fullStr | Metabolic associated fatty liver disease and COVID-19: a double whammy? |
| title_full_unstemmed | Metabolic associated fatty liver disease and COVID-19: a double whammy? |
| title_short | Metabolic associated fatty liver disease and COVID-19: a double whammy? |
| title_sort | metabolic associated fatty liver disease and covid-19: a double whammy? |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678140/ https://www.ncbi.nlm.nih.gov/pubmed/33047142 http://dx.doi.org/10.11622/smedj.2020141 |
| work_keys_str_mv | AT linjaimehuixian metabolicassociatedfattyliverdiseaseandcovid19adoublewhammy AT aravamudanveeraraghavanmeyyur metabolicassociatedfattyliverdiseaseandcovid19adoublewhammy |